KBC Group NV boosted its stake in Aetna Inc. (NYSE:AET) by 42.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 226,420 shares of the company’s stock after buying an additional 68,028 shares during the period. KBC Group NV owned approximately 0.07% of Aetna worth $34,378,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after buying an additional 29,828,390 shares during the period. Vanguard Group Inc. increased its position in Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after buying an additional 838,578 shares in the last quarter. AQR Capital Management LLC increased its position in Aetna by 26.0% in the first quarter. AQR Capital Management LLC now owns 3,639,077 shares of the company’s stock valued at $464,165,000 after buying an additional 751,166 shares in the last quarter. UBS Asset Management Americas Inc. increased its position in Aetna by 29.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,376,132 shares of the company’s stock valued at $303,076,000 after buying an additional 537,604 shares in the last quarter. Finally, Harbour Capital Advisors LLC increased its position in Aetna by 15,083.0% in the second quarter. Harbour Capital Advisors LLC now owns 504,076 shares of the company’s stock valued at $3,320,000 after buying an additional 500,756 shares in the last quarter. 91.69% of the stock is currently owned by institutional investors and hedge funds.

Shares of Aetna Inc. (AET) opened at 155.81 on Friday. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $161.69. The stock has a market capitalization of $51.74 billion, a PE ratio of 34.59 and a beta of 0.54. The company’s 50 day moving average price is $154.74 and its 200-day moving average price is $140.10.

Aetna (NYSE:AET) last released its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same period in the previous year, the firm posted $2.21 EPS. Aetna’s revenue for the quarter was down 2.7% on a year-over-year basis. Equities research analysts predict that Aetna Inc. will post $9.55 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/18/kbc-group-nv-purchases-68028-shares-of-aetna-inc-aet.html.

AET has been the topic of several analyst reports. Royal Bank Of Canada reissued a “buy” rating and set a $145.00 target price on shares of Aetna in a research report on Monday, April 24th. Bank of America Corporation reissued a “buy” rating and set a $168.00 target price (up previously from $160.00) on shares of Aetna in a research report on Wednesday, May 17th. Morgan Stanley initiated coverage on Aetna in a research report on Tuesday, June 6th. They set an “overweight” rating and a $162.00 target price on the stock. Jefferies Group LLC reissued a “hold” rating and set a $163.00 target price (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Finally, Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a research report on Tuesday, July 4th. Seven investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Aetna currently has an average rating of “Buy” and an average price target of $157.99.

In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.90% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.